How Has The Size And Value Of The Pen Needles Market Changed During The 2026–2030 Period?
The pen needles market size has grown rapidly in recent years. It will grow from $2.69 billion in 2025 to $2.99 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising global diabetes prevalence, expansion of insulin pen usage, increased availability of self-injection therapies, growth of home healthcare practices, improvements in needle manufacturing technologies.
The pen needles market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing adoption of GLP-1 therapies, rising focus on needle safety regulations, expansion of sustainable disposable medical products, growing demand for painless injection solutions, increasing preference for home-based disease management. Major trends in the forecast period include increasing adoption of ultra-thin pen needles, rising demand for safety pen needle solutions, growing preference for short-length needles, expansion of home-based injection therapies, enhanced focus on patient comfort and compliance.
Claim Your Free Report Sample Today:
What Drivers Are Contributing To The Expansion Trajectory Of The Pen Needles Market?
The increasing prevalence of diabetes is expected to propel the growth of the pen needles market going forward. Diabetes presents as a persistent health issue marked by high blood sugar levels, stemming from inadequate insulin production or the body's ineffective utilization of insulin. The increasing prevalence of diabetes can be attributed to factors such as sedentary lifestyles, unhealthy dietary habits, genetic predisposition, urbanization, and aging populations, compounded by limited access to healthcare and rising obesity rates worldwide. Pen needles are indispensable tools for diabetes management, enabling precise insulin delivery through convenient, minimally invasive injections, promoting better glycemic control, and enhancing patient compliance. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the pen needles market.
Which Primary Segments Are Included In The Detailed Analysis Of The Pen Needles Market?
The pen needles market covered in this report is segmented –
1) By Type: Standard Pen Needles, Safety Pen Needles
2) By Needle Length: Short Length Pen Needles, Medium Length Pen Needles, Long Length Pen Needles
3) By Therapy: Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone
4) By Mode Of Purchase: Retail, Non-Retail
5) By End User: Hospitals And Clinics, Home Healthcare, Other End Users
Subsegments:
1) By Standard Pen Needles: Fixed-Needle Pen Needles, Removable-Needle Pen Needles, Short Pen Needles ( 4mm, 5mm), Long Pen Needles ( 8mm, 12mm)
2) By Safety Pen Needles: Automatic Safety Pen Needles, Manual Safety Pen Needles, Retractable Safety Pen Needles, Shielded Safety Pen Needles
What Current Industry Trends Are Affecting The Performance Of The Pen Needles Market?
Major companies operating in the insulin pen-needle market are focusing on developing innovative solutions, such as advanced multi-bevel needles, to enhance injection comfort and improve patient compliance. Advanced multi-bevel needles are insulin pen needles designed with multiple precision-cut bevels at the tip to make injections smoother, less painful, and more comfortable for patients. For instance, in August 2025, Trividia Health Inc., a US-based diabetes-care company, launched its TRUEplus 5-Bevel Pen Needles in the UK. These pen needles are available in multiple gauges and lengths (e.g., 31 G 5 mm, 6 mm, 8 mm; and 32 G 4 mm), have a silicone coating for reduced friction, have a sterile single-use construction, and have color-coded caps for easy size recognition—all aimed at maximizing comfort, safety, and ease of use. Moreover, they are the lowest-priced 5-bevel pen needles offered on prescription in the UK, making them a cost-effective yet high-quality alternative to older 3-bevel designs.
Which Major Corporations Play A Crucial Role In The Pen Needles Market Landscape?
Major companies operating in the pen needles market are Cardinal Health Inc., Novo Nordisk AS, Becton Dickinson And Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Trividia Health Inc., Medical Technology And Devices S.p.A., Owen Mumford, Dynarex Corporation, UltiMed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., HTL-STREFA S.A., Hindustan Syringes And Medical Devices Ltd., Ypsomed AG, Haselmeier GmbH
Get Your In-Depth Pen Needles Market Report Now:
Which Regions Demonstrate The Highest Growth Momentum In The Pen Needles Market?
North America was the largest region in the pen needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pen needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment